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In vitro activity of a new 'higher-Iactam'
antibacterial agent LY 193239
P. L. BOTHA, E. VORSTER, C. JORDAAN
Summary
In vitro activity ofthe new bicyclic pyrazolidinone LY 193239
(EIi Ully) was evaluated against 52 clinical isolates of Haemo-
phiIus influenzae (4 were .8-lactamase producers), 32 Entero-
coccus faecalis, 14 Neisseria gonorrhoeae (1 .8-lactamase-
positive) and 19 Neisseria meningitidis. Activity was best
against Neisseria spp. and H. influenzae, including penicil-
linase-producing strains. Results of the time-kill study against
a non-enzyme-mediated penicillin resistant strain of N. menin-
gitidis indicate that exposure to an antibacterial concentration
four times the minimal inhibitory concentration was bacteri-
cidal. E. faecalis was insensitive.
S Air Med J 1991; 79: 312-313.
A new group of antibacterial agents, the y-lactams, may now
be added to the .8-lactams. The three-dimensional structure is
nearly superimposable on that of the ,B-lactams but they
contain a five-membered ring instead of the four-membered
ring. The action depends on binding to penicillin-binding
proteins and there is resistance to degradation by the peni-
cillinases although some cephalosporinases may hydrolyse the
y-lactam ring. The activity of the fully synthetic pyrazolidinone
LY 193239 against problem Gram-negative and Gram-positive
pathogens was investigated.
In the RSA there are indications that alternative therapy
and prophylaxis should be sought against meningococcal in-
fections.! H aemophilus influenzae is becoming increasingly resis-
tant to semi-synthetic penicillins and Enterococcus faecalis is a
relatively resistant pathogen. Neisseria gonoTThoeae is also dis-
playing burgeoning resistance to penicillin.
Materials and methods
Bacterial strains. Fifty-two clinical isolates of H. influenzae
(22 were type b) were investigated. Four were resistant to
ampicillin (minimal inhibitory concentration (MIC) >32 mg/l)
and produced .8-lacramase. Apart froni 1 cerebrospinal fluid
(CSF) isolate the others were all respiratory tract pathogens.
Of 32 E. faecalis 2 were urinary tract isolates and 1 was from a
blood culture while the remainder were isolated from pus.
Half of these strains were resistant to ampicillin with ampicillin
MICs >512 mg/l. Fourteen N. gonoTThoeae strains were all
genital isolates and 1 ,B-lactamase-producing strain showed a
penicillin MIC >64 mg/l. Nineteen N. meningicidis isolates (7
from CSFs and the remainder from blood cultures) wer~ all
fully sensitive to penicillin (MIC <0,05 mg/l), except 1 CSF
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isolate, which was only inhibited (and killed) by 1 mg/l
penicillin.
Antimicrobial agents. Solutions of LY 193239 (supplied
by Eli Lilly) and tetracycline were freshly prepared in sterile
distilled water. Rifampicin was dissolved in dimethyl sul-
phoxide and diluted in water. Ampicillin and penicillin were
prepared in 0,05M phosphate buffer with final pH 7,0.
MICs. MICs were determined by inoculating appropriate-
dilutions of log-phase test organisms in serum broth onto
freshly prepared chocolate agar media containing appropriate
concentrations of individual antibiotics or antibacterial agent
with a multipoint inoculator (Mast) so that each tine delivered
5 X 106 colony forming units (CFUs). In the case of E. faecalis
2% sheep blood agar plates were used. Plates were incubated
for 18 hours at 37°C in air or under 5% CO2 as required by
the organisms investigated. The lowest concentration of anti-
biotic or antibacterial agent totally inhibiting growth was
regarded as the MIC.
Time-kill curve.2 Data for the time-kill study were obtain~d
after MIC determination. Several 500 ml flasks containing 300
ml Mueller-Hinton broth with appropriate quantities of LY
193239 were prepared. Each flask was inoculated with approxi-
mately 3 X 108 CFU/ml. Samples of 100 III were removed
immediately and serial 10-fold dilutions were prepared for
colony counts. Cultures were incubated at 37°C and CO2 was
passed through the medium. Further duplicate samples for
viable colony estimation were similarly diluted in Mueller-
Hinton broth and inoculated by spreading 100 III on chocolate
agar plates at 6 hours and 24 hours.
Results
MICs
Results of agar dilution susceptibility studies are shown in
Table 1. .
Activity of LY 193239 is excellent against the two Neisseria
species tested. Beta-laetamase-producing strains of Neisseria
and Haemophilus remain sensitive to LY 193239. E. faecalis is
highly resistant and this resistance appears independent of
ampicillin sensitivity.
Time-kill study
The time-kill curves for differing concentrations of LY
193239 ploned against a non-.8-lactamase-producing but rela-
tively penicillin-resistant strain of N. meningicidis (MIC =
1 mg/l) are shown in Fig. 1. Four times (0,192 mg/l) the LY
193239 MIC (0,048 mg/l) is bactericidal.
Discussion
With the limited resources at their disposal micro-organisms
continue to evade the action of antibiotics with remarkable
success. In the absence·of satisfactory vaccines for meningo-
coccal disease,3 it is important that novel antibiotics or anti-
bacterial agents be developed and assessed. The prevalence of .
N. gonoTThoeae infections and escalating resistance to fIrst-line
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TABLE'I. COMPARATIVE IN VITRO ACTIVITV OF LV 193239 AGAINST CLINICAL ISOLATES
MIC mgll for strains
Antibiotic! "
Strain (No.) antimicrobial 50% 90% MIC range (mg/I)
H. influenzae (48) LV 193293 <;;: 1,56 <;;: 3,125 0,78 - 12,5
Non-I3-lactamase Ampicillin <;;: 0,5 ~ 0,5 0,125 - 2,0
iJ-lactamase (4) LV 193293 3,125 3,125 0,78 - 3,125
Ampicillin 64,0 128,0 32,0 - 128,0
E. faecalis (32) LV 193293 > 100 > 100 25 - >100
Ampicillin 0,5 > 512 0,5 - >512
N. gonorrhoeae (14) LV 193293 0,195 0,195 0,195 - 0,195
Penicillin 0,03 0,125 < 0,01 - 256·
Tetracycline 1,0 1,0 0,5 - 2,0
N. meningitidis (19) LV 193239 0,048 0,048 0,048 - 0,048
Penicillin 0,125 0,125 0,03 - 1,0
Rifampicin 0,06 0,125 0,01 - 0,25
• Penicillinase-producing
-->!- Control --+--- 1/2 MIC ---¥-- MIC -e- 4 x MIC
The chemical stability of LY 193239 makes it an anractive
prospect (J. Temansky, Eli Lilly Research Division - per-
sonal communication).
In the CSF levels of penicillin approach 0,8 mgll, which is
not bactericidal for certain local strains examined in this and
another study.l
Rifampicin is widely used in antituberculosis therapy so that
other organisms present in the community (N. meningiridis in
the carrier state) may develop resistance to it. Conversely,
rifampicin should probably be reserved for antituberculosis
therapy in this country for similar reasons of resistance occur-
ring in Mycobacrerium ruberculosis exposed to rifampicin used
for other purposes, such as contacts of meningococcal disease
patients. In this context LY 193239 may also have a place in
the clinical setting. .
It may be concluded that future clinical prescription of LY
193239 will prove valuable against Neisseria and Haemophilus
infections and the indications are that penicillinase production
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Fig. 1. Activity at differing concentrations of LV 193239 on a
relatively penicillin-resistant but non-,B-Iactamase-producing strain
of N. meningitidis isolated from CSF (penicillin MIC = 1 mgll; LV
193239 MIC = 0,48 mgll).
drugs also demand attention. Community-acquired Haemophilus
infections lower school attendance and productivity. Consider-
ation of inherently difficult to treat endogenous enterococcal
infections is important.
In this study the bicyclic pyrazolidinone LY 193239 dis-
played excellent activity against Neisseria spp. and against H.
inJluenzae, particularly against {3-lactamase-producing strains.
Enterococci emerged unaffected by this drug.
We wish to thank Eli Lilly for the opportunity to investigate the
activity of LY 193239 on clinical isolates from the local environ-
ment.
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